General Information of Drug (ID: DM1J3LE)

Drug Name
PMID25980951-Compound-16 Drug Info
Cross-matching ID
PubChem CID
50913339
TTD Drug ID
DM1J3LE

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AT-406 DMVJW0S Squamous head and neck cell carcinom 2D60.0 Phase 3 [2]
Birinapant DM6PBUM Lymphoma 2A80-2A86 Phase 2 [3]
PMID25980951-Compound-6 DMVSW5N N. A. N. A. Patented [1]
PMID25980951-Compound-27 DMXAH9F N. A. N. A. Patented [1]
PMID25980951-Compound-43 DMTJRCS N. A. N. A. Patented [1]
PMID25980951-Compound-1 DMYPT2H N. A. N. A. Patented [1]
PMID25980951-Compound-44 DMS5896 N. A. N. A. Patented [1]
PMID25980951-Compound-3 DMPSWXU N. A. N. A. Patented [1]
PMID25980951-Compound-4 DM9RZSH N. A. N. A. Patented [1]
PMID25980951-Compound-21 DMIE0MR N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cellular inhibitor of apoptosis 1 (BIRC2) TTQ5LRD BIRC2_HUMAN Antagonist [1]

References

1 Small molecule inhibitor of apoptosis proteins antagonists: a patent review.Expert Opin Ther Pat. 2015 Jul;25(7):755-74.
2 Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung c... Am J Cancer Res. 2014 Nov 19;4(6):943-51.
3 cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood. 2014 Apr 17;123(16):2562-72.